Sarepta Therapeutics, Inc 10-Q for FY2024 Q2
Sarepta Therapeutics, Inc. (SRPT)
10-Q
2024-08-07
For: 2024-06-30
View Original
Added on
April 11, 2026
About this 10-Q
Sarepta Therapeutics, Inc filed this 10-Q on August 7, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).
Headline figures
Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $362.93M
- up 38.9% from $261.24M a year earlier
- Net income
- $6.46M
- compared with a net loss of $23.94M a year earlier
- Diluted EPS
- $0.07
- compared with -$0.27 a year earlier